Somatic gain of function mutations of PTPN11, the gene coding for SHP2, cause 35% of juvenile myelomonocytic leukemia (JMML) cases and are found in other hematologic malignancies and tumors [1], [3], [4], [5]. Here, PTPN11 is linked to hematologic disorder.